BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 11287448)

  • 1. Gender- and smoking-related bladder cancer risk.
    Castelao JE; Yuan JM; Skipper PL; Tannenbaum SR; Gago-Dominguez M; Crowder JS; Ross RK; Yu MC
    J Natl Cancer Inst; 2001 Apr; 93(7):538-45. PubMed ID: 11287448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
    Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
    J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione S-transferase M1 genotype affects aminobiphenyl-hemoglobin adduct levels in white, black and Asian smokers and nonsmokers.
    Yu MC; Ross RK; Chan KK; Henderson BE; Skipper PL; Tannenbaum SR; Coetzee GA
    Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):861-4. PubMed ID: 8634658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County.
    Jiang X; Yuan JM; Skipper PL; Tannenbaum SR; Yu MC
    Cancer Res; 2007 Aug; 67(15):7540-5. PubMed ID: 17671226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonsmoking-related arylamine exposure and bladder cancer risk.
    Skipper PL; Tannenbaum SR; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):503-7. PubMed ID: 12814994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carotenoids/vitamin C and smoking-related bladder cancer.
    Castelao JE; Yuan JM; Gago-Dominguez M; Skipper PL; Tannenbaum SR; Chan KK; Watson MA; Bell DA; Coetzee GA; Ross RK; Yu MC
    Int J Cancer; 2004 Jun; 110(3):417-23. PubMed ID: 15095308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California.
    Yu MC; Skipper PL; Taghizadeh K; Tannenbaum SR; Chan KK; Henderson BE; Ross RK
    J Natl Cancer Inst; 1994 May; 86(9):712-6. PubMed ID: 8158701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Black (air-cured) and blond (flue-cured) tobacco cancer risk. IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens.
    Bartsch H; Malaveille C; Friesen M; Kadlubar FF; Vineis P
    Eur J Cancer; 1993; 29A(8):1199-207. PubMed ID: 8518034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tobacco use in relation to renal cell carcinoma.
    Yuan JM; Castelao JE; Gago-Dominguez M; Yu MC; Ross RK
    Cancer Epidemiol Biomarkers Prev; 1998 May; 7(5):429-33. PubMed ID: 9610793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of bladder cancer by source and type of tobacco exposure: a case-control study.
    Burch JD; Rohan TE; Howe GR; Risch HA; Hill GB; Steele R; Miller AB
    Int J Cancer; 1989 Oct; 44(4):622-8. PubMed ID: 2793235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the type of cigarette smoked on bladder cancer risk.
    Wynder EL; Augustine A; Kabat GC; Hebert JR
    Cancer; 1988 Feb; 61(3):622-7. PubMed ID: 3338029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Aminobiphenyl-hemoglobin adducts and risk of smoking-related disease in never smokers and former smokers in the European Prospective Investigation into Cancer and Nutrition prospective study.
    Airoldi L; Vineis P; Colombi A; Olgiati L; Dell'Osta C; Fanelli R; Manzi L; Veglia F; Autrup H; Dunning A; Garte S; Hainaut P; Hoek G; Krzyzanowski M; Malaveille C; Matullo G; Overvad K; Tjonneland A; Clavel-Chapelon F; Linseisen J; Boeing H; Trichopoulou A; Palli D; Peluso M; Krogh V; Tumino R; Panico S; Bueno-De-Mesquita HB; Peeters PH; Lund E; Agudo A; Martinez C; Dorronsoro M; Barricarte A; Chirlaque MD; Quiros JR; Berglund G; Järvholm B; Hallmans G; Day NE; Allen N; Saracci R; Kaaks R; Riboli E
    Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2118-24. PubMed ID: 16172219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
    Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case-control study of smoking and bladder cancer risk: emergent patterns over time.
    Baris D; Karagas MR; Verrill C; Johnson A; Andrew AS; Marsit CJ; Schwenn M; Colt JS; Cherala S; Samanic C; Waddell R; Cantor KP; Schned A; Rothman N; Lubin J; Fraumeni JF; Hoover RN; Kelsey KT; Silverman DT
    J Natl Cancer Inst; 2009 Nov; 101(22):1553-61. PubMed ID: 19917915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette tar yields in relation to mortality from lung cancer in the cancer prevention study II prospective cohort, 1982-8.
    Harris JE; Thun MJ; Mondul AM; Calle EE
    BMJ; 2004 Jan; 328(7431):72. PubMed ID: 14715602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender.
    Samanic C; Kogevinas M; Dosemeci M; Malats N; Real FX; Garcia-Closas M; Serra C; Carrato A; García-Closas R; Sala M; Lloreta J; Tardón A; Rothman N; Silverman DT
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1348-54. PubMed ID: 16835335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco smoke inhalation pattern, tobacco type, and bladder cancer in Spain.
    López-Abente G; González CA; Errezola M; Escolar A; Izarzugaza I; Nebot M; Riboli E
    Am J Epidemiol; 1991 Oct; 134(8):830-9. PubMed ID: 1951278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels.
    Landi MT; Zocchetti C; Bernucci I; Kadlubar FF; Tannenbaum S; Skipper P; Bartsch H; Malaveille C; Shields P; Caporaso NE; Vineis P
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):693-8. PubMed ID: 8877060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinogen hemoglobin adducts, urinary mutagenicity, and metabolic phenotype in active and passive cigarette smokers.
    Bartsch H; Caporaso N; Coda M; Kadlubar F; Malaveille C; Skipper P; Talaska G; Tannenbaum SR; Vineis P
    J Natl Cancer Inst; 1990 Dec; 82(23):1826-31. PubMed ID: 2250298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation.
    Vineis P; Kogevinas M; Simonato L; Brennan P; Boffetta P
    Mutat Res; 2000 Jul; 463(1):103-10. PubMed ID: 10928863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.